Bariatric surgery gastric sleeve, also known as sleeve gastrectomy, is one of the most commonly performed weight-loss procedures in the UK. By permanently removing around 75–80% of the stomach, it reduces food intake and alters hunger-regulating hormones, supporting significant and sustained weight loss. Recognised within NICE guidance (CG189) as part of a clinically effective bariatric pathway, it is available on the NHS for eligible patients and privately across the UK. This article explains how the procedure works, who qualifies, what to expect before and after surgery, and the long-term lifestyle commitments required for lasting success.

What Is Gastric Sleeve Surgery and How Does It Work?

Sleeve gastrectomy permanently removes 75–80% of the stomach laparoscopically, restricting food intake and reducing ghrelin levels to decrease appetite, with additional metabolic benefits including potential improvement of type 2 diabetes.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, medically known as sleeve gastrectomy, is a form of bariatric (weight-loss) surgery in which approximately 75–80% of the stomach is permanently removed, leaving a narrow, tube-shaped 'sleeve' roughly the size and shape of a banana. This significantly reduces the stomach's capacity, meaning patients feel full much more quickly after eating smaller portions.

Beyond the mechanical restriction of food intake, the procedure also has important hormonal effects. The portion of the stomach that is removed contains the majority of cells responsible for producing ghrelin — often referred to as the 'hunger hormone'. Reducing ghrelin levels can help decrease appetite. The surgery also appears to increase levels of gut hormones such as GLP-1 and PYY, which further support appetite regulation and may contribute to improvements in blood glucose control. For this reason, sleeve gastrectomy can lead to significant metabolic benefits, including remission or improvement of type 2 diabetes in some patients, though individual outcomes vary.

In terms of weight loss, UK registry data suggest patients may lose around 60–70% of their excess body weight over the first one to two years, though results vary considerably between individuals and depend heavily on adherence to dietary and lifestyle changes.

Gastric sleeve surgery is performed laparoscopically (keyhole surgery) under general anaesthetic. Operative time and length of hospital stay vary by centre and patient factors; conversion to open surgery is uncommon but possible. Unlike gastric bypass surgery, sleeve gastrectomy does not reroute the digestive tract, which gives it a different risk profile. It is a permanent intervention, as the removed portion of the stomach cannot be restored.

The procedure is recognised by NICE (National Institute for Health and Care Excellence) within its guidance on obesity management (CG189) as part of a clinically effective bariatric surgical pathway, delivered within a multidisciplinary team (MDT). NICE does not recommend one bariatric procedure over another; the most appropriate option is determined through MDT assessment. It is important to understand that gastric sleeve surgery is a tool to support weight management — long-term success depends heavily on sustained dietary and lifestyle changes following the operation.

Who Is Eligible for Bariatric Surgery on the NHS?

NHS eligibility requires a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with a significant obesity-related condition; lower thresholds apply for certain ethnic groups, and recent-onset type 2 diabetes warrants expedited assessment.

Eligibility for bariatric surgery on the NHS is guided by NICE Clinical Guideline CG189 (Obesity: identification, assessment and management), NICE Guideline NG28 (Type 2 diabetes in adults: management), and NHS England commissioning criteria. Patients are generally considered eligible if they meet specific clinical thresholds:

• BMI of 40 kg/m² or above, or

• BMI of 35–39.9 kg/m² with a significant obesity-related health condition such as type 2 diabetes, hypertension, obstructive sleep apnoea, or joint disease

• In some cases, individuals with a BMI of 30–34.9 kg/m² and recent-onset type 2 diabetes may also be considered

• For people of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family origin, BMI thresholds are typically reduced by approximately 2.5 kg/m², reflecting higher metabolic risk at lower BMI values

• Surgery may be considered as a first-line option for people with a BMI of 50 kg/m² or above, where other interventions are unlikely to achieve sufficient benefit

People with recent-onset type 2 diabetes should be considered for expedited assessment, as evidence supports significant metabolic benefits from bariatric surgery in this group, including the possibility of diabetes remission.

In addition to BMI criteria, patients must typically demonstrate that:

• All appropriate non-surgical weight management interventions have been tried and have not achieved or maintained adequate clinically beneficial weight loss

• They are fit for anaesthesia and surgery

• They commit to long-term follow-up and lifestyle changes

• They do not have specific contraindications, such as untreated or unstable psychiatric conditions, active substance misuse, active eating disorders, or an inability to engage with long-term follow-up

Referral is usually made through a specialist tier 3 weight management service, which provides multidisciplinary assessment including dietary, psychological, and medical evaluation before any surgical pathway is considered. The duration of tier 3 involvement varies by local policy and individual clinical need.

Eligibility criteria and service availability can vary between NHS trusts and integrated care boards (ICBs). Patients are encouraged to speak with their GP to understand what is available locally and to obtain information on local commissioning policies.

What to Expect Before, During and After the Procedure

Before surgery, patients follow a liver-shrinking diet for two to four weeks; after the laparoscopic procedure, dietary intake progresses from fluids to solids over six weeks, with lifelong supplementation and follow-up required.

Before surgery, patients undergo a thorough pre-operative assessment, which typically includes blood tests, cardiovascular evaluation, nutritional screening, and psychological assessment. Most NHS programmes require patients to follow a low-calorie or liver-shrinking diet for two to four weeks prior to surgery. This reduces the size of the liver, which overlies the stomach, making the operation safer and technically easier for the surgical team.

Patients will also receive detailed counselling about the permanent nature of the procedure, expected outcomes, and the lifestyle commitments required post-operatively. Smoking cessation is strongly advised, as smoking significantly increases surgical and anaesthetic risk.

During the procedure, the surgeon uses laparoscopic instruments inserted through small incisions in the abdomen. The majority of the stomach is stapled and removed, leaving the sleeve-shaped remnant. Most patients are discharged within one to two days, provided there are no complications.

After surgery, the recovery period involves a structured dietary progression, though exact protocols vary between bariatric centres:

• Weeks 1–2: Fluids only (water, diluted juice, thin soups)

• Weeks 3–4: Pureed and soft foods

• Weeks 5–6: Gradual reintroduction of solid foods

Typical targets during recovery include at least 60–80 g of protein per day to preserve muscle mass, and 1.5–2.0 litres of fluid per day. Fluids should generally be consumed separately from meals — most bariatric teams advise avoiding drinking for approximately 30 minutes before and after eating.

Fatigue is common in the early weeks, and patients are usually advised to take two to four weeks off work, depending on the nature of their employment. Patients should check with their insurer and follow DVLA guidance before returning to driving, and should avoid heavy lifting for several weeks as directed by their surgical team.

A short course of a proton pump inhibitor (PPI) is commonly prescribed following surgery to reduce the risk of reflux and ulceration; patients should follow their local protocol. NSAIDs (such as ibuprofen or naproxen) should be avoided unless a clinician has specifically advised their use alongside appropriate gastroprotection, as they increase the risk of ulceration in the sleeve.

If persistent vomiting occurs in the post-operative period, patients should seek prompt clinical review. Prolonged vomiting carries a risk of thiamine (vitamin B1) deficiency, which can cause serious neurological complications (Wernicke's encephalopathy); urgent thiamine supplementation may be required.

Patients of childbearing age are advised to avoid pregnancy for at least 12–18 months after surgery, as rapid weight loss during this period can affect foetal development. Reliable contraception should be used during this time. When planning a pregnancy after this period, a higher-dose folic acid supplement (5 mg daily) is recommended; patients should discuss this with their GP or bariatric team.

Regular follow-up appointments with the bariatric team — including dietitian support — are essential during the first two years. Patients should also begin taking long-term vitamin and mineral supplements as directed by their bariatric team. Nutrient deficiencies following sleeve gastrectomy arise primarily from reduced food intake and changes in gastric physiology (including reduced acid and intrinsic factor production) rather than intestinal malabsorption. Specific supplement regimens should follow BOMSS (British Obesity and Metabolic Surgery Society) guidance and be tailored to the individual.

Risks, Complications and Long-Term Considerations

Short-term risks include staple-line leakage and blood clots; long-term risks include gastro-oesophageal reflux, nutritional deficiencies, and weight regain, requiring lifelong monitoring per BOMSS guidance.

As with any major surgical procedure, gastric sleeve surgery carries both short-term and long-term risks. Patients should be fully informed of these before consenting to the operation.

Short-term risks include:

• Bleeding or infection at the surgical site

• Leakage from the staple line — a serious but uncommon complication; rates at UK high-volume centres are typically around 1% or below, though this varies by centre and patient factors

• Stricture or narrowing of the sleeve

• Blood clots (deep vein thrombosis or pulmonary embolism)

• Adverse reactions to anaesthesia

• Nausea and vomiting in the immediate post-operative period

• Incisional hernia

Urgent red-flag symptoms requiring immediate medical attention (call 999 or go to A&E) include: severe chest pain, breathlessness, rapid heart rate, calf pain or swelling, high fever, inability to keep fluids down, vomiting blood, or passing black tarry stools. Patients should also contact their GP or bariatric team promptly for persistent vomiting, severe abdominal pain, or signs of infection.

Long-term considerations include:

• Gastro-oesophageal reflux disease (GORD): Some patients experience worsening or new-onset acid reflux following sleeve gastrectomy. In certain cases, this may necessitate conversion to gastric bypass surgery.

• Gallstone formation: Rapid weight loss increases the risk of gallstones. Some bariatric centres prescribe a short course of ursodeoxycholic acid prophylactically; patients should follow their local protocol.

• Nutritional deficiencies: Deficiencies in vitamin B12, iron, vitamin D, calcium, folate, and — in some cases — trace elements are well-documented. Lifelong supplementation is required. Annual blood monitoring is recommended as a minimum, following the BOMSS monitoring schedule, which typically includes FBC, ferritin, vitamin B12, folate, vitamin D, calcium, PTH, and renal and liver function tests.

• Thiamine deficiency: Patients with prolonged vomiting or poor dietary intake are at risk; early clinical review and supplementation are important.

• Alcohol sensitivity: Some patients notice increased sensitivity to alcohol following surgery, with faster absorption and stronger effects. Caution is advised.

• Weight regain: Some patients experience partial weight regain after several years, particularly if dietary and behavioural changes are not maintained.

• Sleeve dilation: Over time, the sleeve may gradually expand, which can contribute to weight regain.

• Psychological impact: Changes in body image and eating behaviour can affect mental health. Ongoing psychological support is an important component of aftercare.

If you experience any problems that you suspect may be related to medicines or medical devices used during or after your surgery (for example, anaesthetic agents or surgical stapling devices), these can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Life After Gastric Sleeve Surgery: Diet and Lifestyle Changes

Long-term success requires structured meals prioritising protein, at least 1.5–2.0 litres of fluid daily, lifelong vitamin supplementation, and at least 150 minutes of moderate aerobic activity per week.

Long-term success following gastric sleeve surgery is closely tied to sustained changes in diet, physical activity, and overall lifestyle. The surgery provides a powerful physiological tool, but it does not replace the need for behavioural commitment.

Dietary guidance after the initial recovery phase includes:

• Eating structured meals — typically three small meals per day — prioritising protein at each meal and avoiding unplanned grazing between meals. Some bariatric dietitians may recommend planned protein-rich snacks if individual targets are not being met; follow the advice of your own dietitian.

• Aiming for at least 60–80 g of protein per day (from lean meat, fish, eggs, dairy, legumes, or protein supplements if advised) to preserve muscle mass

• Aiming for 1.5–2.0 litres of fluid per day, avoiding drinking for approximately 30 minutes before and after meals to prevent the sleeve from filling too quickly

• Chewing food thoroughly and eating slowly to avoid discomfort

• Avoiding high-calorie, high-sugar, or high-fat foods, which can cause discomfort or undermine weight loss

• Avoiding carbonated drinks, which can cause bloating and discomfort

• Avoiding NSAIDs (such as ibuprofen) unless specifically advised by a clinician with appropriate gastroprotection

• Exercising caution with alcohol: absorption is faster after sleeve gastrectomy, meaning the effects of alcohol are felt more quickly and more strongly than before surgery

Lifelong vitamin and mineral supplementation is essential. Regimens should be guided by your bariatric team and aligned with BOMSS recommendations, typically including a complete multivitamin and mineral supplement, vitamin D, calcium citrate, and vitamin B12 (by injection or high-dose oral preparation). Annual blood tests should be arranged through your GP to monitor nutritional status, following the BOMSS monitoring schedule.

Physical activity plays a vital role in maintaining weight loss and improving cardiovascular and metabolic health. Patients are generally encouraged to begin gentle walking shortly after surgery, building gradually towards at least 150 minutes of moderate-intensity aerobic activity per week. In line with UK Chief Medical Officers' Physical Activity Guidelines (2019), patients should also aim to include muscle-strengthening activities on at least two days per week, which helps preserve lean muscle mass during weight loss.

Pregnancy and contraception: Reliable contraception should be used for at least 12–18 months post-operatively. When planning a pregnancy after this period, discuss folic acid supplementation (5 mg daily is typically recommended) and nutritional monitoring with your GP or bariatric team.

Psychological wellbeing should not be overlooked. Some individuals find that changes in their relationship with food, body image, or social eating require ongoing support. Patients are encouraged to access counselling or support groups where available, and to raise any concerns with their bariatric team.

Accessing Bariatric Surgery Through the NHS or Privately

NHS access begins with a GP referral to a tier 3 weight management service; private gastric sleeve surgery costs approximately £8,000–£12,000, and providers should be CQC-registered with GMC-listed surgeons and comprehensive aftercare.

NHS access to gastric sleeve surgery begins with a GP referral. If a patient meets the initial eligibility criteria, they will typically be referred to a tier 3 specialist weight management service for a structured programme of dietary, physical activity, and behavioural support. The duration of this programme varies by local policy and individual clinical need. Following successful completion, patients are referred to a bariatric surgical centre for further assessment and, if appropriate, surgery.

Waiting times on the NHS can be lengthy, and availability varies significantly between integrated care boards (ICBs). Some areas have more limited access to bariatric services. Patients may wish to discuss options with their GP or contact their local ICB for information on commissioning policies.

Following surgery, patients can typically expect at least two years of specialist follow-up with the bariatric team, after which ongoing lifelong annual monitoring is usually transferred to the GP, with agreed responsibilities for nutritional blood tests and general health review.

Private bariatric surgery is available at a number of independent hospitals and clinics across the UK. The cost of a gastric sleeve procedure privately is approximately £8,000 to £12,000, though this varies by provider, geography, and the scope of aftercare included; patients should confirm exactly what is covered before proceeding. When considering private treatment, patients should ensure the provider:

• Is registered with the Care Quality Commission (CQC) (verifiable via the CQC provider directory)

• Employs surgeons listed on the GMC Specialist Register with appropriate bariatric or upper gastrointestinal surgical experience

• Offers comprehensive pre-operative MDT assessment and long-term aftercare, including dietitian and psychological support

• Has clear protocols for managing complications, including emergency cover

• Participates in the National Bariatric Surgery Registry (NBSR), which collects UK outcomes and complication data — participation reflects a commitment to quality and transparency

Regardless of whether surgery is accessed through the NHS or privately, long-term follow-up — including nutritional monitoring, dietitian support, and psychological care — is an essential component of safe and effective bariatric care. Patients should never view surgery as a standalone solution, but as part of a broader, lifelong commitment to health.

If you experience any problems that you suspect may be related to medicines or medical devices used in connection with your surgery, please report these via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Frequently Asked Questions